Back to search
Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
Data up to Jan 2025
Published2000
Citations36
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...